343 research outputs found
Landform Classification by Machine Processing of Remotely Second Data - A Case Study of the Sendai Coastal Plain
Giant enhancement of cryogenic thermopower by polar structural instability in the pressurized semimetal MoTe2
We found that a high mobility semimetal 1T'-MoTe2 shows a significant
pressure-dependent change in the cryogenic thermopower in the vicinity of the
critical pressure, where the polar structural transition disappears. With the
application of a high pressure of 0.75 GPa, while the resistivity becomes as
low as 10 {\mu}{\Omega}cm, thermopower reached the maximum value of 60
{\mu}VK-1 at 25 K, leading to a giant thermoelectric power factor of 300
{\mu}WK-2cm-1. Based on semiquantitative analyses, the origin of this behavior
is discussed in terms of inelastic electron-phonon scattering enhanced by the
softening of zone center phonon modes associated with the polar structural
instability.Comment: 13 pages, 4 figures Physical review B (accepted
TWO-STAGED CLASSIFICATION BY LEFT VENTRICULAR EJECTION FRACTION FOLLOWED BY EXTENT OF LATE GADOLINIUM ENHANCEMENT IN CARDIAC MAGNETIC RESONANCE IS USEFUL FOR RISK STRATIFICATION IN HYPERTROPHIC CARDIOMYOPATHY
RESERVOIR FUNCTION OF LEFT ATRIUM IS IMPAIRED IN PATIENTS WITH HEART FAILURE AND SEVERE MITRAL REGURGITATION
Characteristics of Clinical and Imaging Findings of Epidermoid Cysts under the Skin of the Mental Region
Epidermoid cyst often arises in the fl oor of oral cavity; however, it is relatively rare to arise subcutaneously in the mental region. We reported characteristics of clinical and imaging fi ndings of epidermoid cysts under the skin of the mental region. The patient was a 53-year-old male. He complained of a subcutaneous mass without pain in the left mental region. A palpable soft and movable thumb-sized mass without pain was observed at the fi rst examination. Ultrasound examination revealed a well-demarcated mass with heterogenous hyper-echoic internal echo and posterior echo enhancement. On power Doppler sonography, a small amount of blood supply was found around the periphery of the mass. Plain CT scan revealeda globular soft-tissue mass with peripheral high and central low CT values area. The mass was removed under local anesthesia using intraoral approach. A histopathologic diagnosis was epidermoid cyst. Recurrence is not observed 2 years after surgery. There were only 3 reports of epidermoid cysts in the mental region, including our case in Japan, clinically characteristics of age ranging 20 to 66 years of age and the mean age of 46 years, with 2 males and 1 female. The size wasfrom 20 mm to 12 mm in diameter and from the tip of a thumb up to the tip of a small fi nger. Ultrasound images of the inside of epidermoid cysts that we experienced this time showed enhancement of relatively uniform hyperechoic image and posterior echo, which was characteristically slightly diff erent from fi ndings of epidermoid cysts generally reported
Long-term outcomes of microendoscopic laminoplasty in patients with lumbar spinal stenosis: impact of the surgical approach and facet tropism
Microendoscopic laminoplasty (MEL) is the surgical procedure of choice at our institution for decompressing nerve roots in lumbar spinal stenosis (LSS). This minimally invasive procedure allows for bilateral decompression via unilateral endoscopic surgical access and maximum preservation of the lumbar zygapophyseal (facet) joints at the level (s) of interest. For this procedure, the surgical approach is generally made on the ipsilateral side of the stenosis. However, this rule of thumb is not always applicable because of lumbar facet joint degeneration and variations in the long-axis orientation of the spinous processes. Few studies to date have proposed criteria about the surgical approach for MEL. Surgeons use their clinical judgment to decide on a case-by-case basis. Facet tropism is frequently encountered in patients with LSS undergoing MEL. Long-term postoperative changes in spinal alignment parameters could guide selection of the side for the surgical approach in MEL. This retrospective study included 45 patients who underwent MEL for single-level LSS between April 1, 2010 and June 30, 2014. The mean age of the patients was 74.8 ± 8.2 years; 23 (51%) were male. FT was defined as a bilateral facet joint angle difference of ≥10 degrees. Study variables included lumbar lordosis angle, Cobb angle, and vertebral slippage based on standing radiographic images. The study population was divided into two groups based on the degree of facet joint sagittal orientation on the side of the incision. Specifically, patients in whom the surgical approach was made on the side of the more sagittally oriented facet joint were categorized into Group S. The other patients were categorized into Group N. The percent change in mean Cobb angle between preoperative and postoperative assessments was 124 ± 164% for Group S and 45.6 ± 62.5% for Group N (P < 0.05), indicating postoperative progression of scoliosis in Group S. Considering the postoperative risk of scoliosis and related complications, approaching from the side of the less sagittally oriented facet joint is preferable in MEL for the treatment of LSS in patients with FT
Impact of noncontrast PCI for ACS
Purpose : Contrast-induced acute kidney injury (CI-AKI) is one of the common serious complications of percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). This study aimed to assess the significance of noncontrast strategy in the setting of ACS. Methods : CI-AKI was defined as an increase in serum creatinine of ≥ 0.5 mg / dL or ≥ 1.25 times from the baseline. One-year worsening renal function (WRF) was defined as an increase of ≥ 0.3 mg / dL in serum creatinine from the baseline after PCI. Results : Of 250 ACS patients, 81 were treated with noncontrast PCI. The average doses of contrast medium in the noncontrast and conventional groups were 17 (9–22) ml and 150 (120–200) ml, respectively. CI-AKI was observed in 4 patients (5%) in the noncontrast group and 29 patients (17%) in the conventional group. Noncontrast PCI was associated with a lower incidence of CI-AKI (adjusted odds ratio, 0.26 ; 95% confidence interval [CI], 0.08–0.82). The bootstrap method and inverse probability weighting led to similar results. CI-AKI was associated with a higher incidence of 1-year WRF (adjusted hazard ratio, 2.30 ; 95% CI, 1.12–4.69), while noncontrast PCI was not. Conclusions : Noncontrast PCI was associated with the lower incidence of CI-AKI in ACS patients
Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
Oxidative stress is enhanced by various mechanisms. Serum oxidized low-density lipoprotein (LDL) is a useful prognostic marker in diabetic patients with coronary artery disease. To examine the effects of Theracurmin®, a highly absorbable curcumin preparation, on glucose tolerance, adipocytokines, and oxidized LDL, we conducted a double-blind placebo-controlled parallel group randomized trial in patients with impaired glucose tolerance or non-insulin-dependent diabetes mellitus. We randomly divided the patients with impaired glucose tolerance or non-insulin-dependent diabetes mellitus and stable individuals into the placebo group and the Theracurmin® (180 mg daily for 6 months) group. Of the 33 patients analyzed, 18 (14 males and 4 females) were administered placebo and 15 (9 males and 6 females) were administered Theracurmin®. The patient characteristics did not differ between the two groups. The primary endpoint, HbA1c, did not differ significantly between the two groups. However, the level of α1-antitrypsin-low-density lipoprotein (AT-LDL), the oxidized LDL, significantly increased (p = 0.024) in the placebo group from the beginning of the trial up to 6 months, although there was no such change in the Theracurmin® group. The percentage change in BMI from the beginning of the trial up to 6 months tended to be higher in the Theracurmin® group than in the placebo group. Patients in the Theracurmin® group tended to have a larger percentage change in adiponectin and LDL-C than those in the placebo group. Patients in the Theracurmin® group showed a smaller percentage change in AT-LDL than those in the placebo group. This study suggests that the highly absorbable curcumin could potentially inhibit a rise in oxidized LDL in patients with impaired glucose tolerance or non-insulin-dependent diabetes mellitus. This trial is registered with UMIN000007361
- …